 |
On December 13, 2005, Siskinds filed a class proceeding against Pfizer Canada Inc. and Pfizer Inc. with respect to Depo-Provera. Depo-Provera is typically prescribed to prevent pregnancy, however, it is also used to treat endometriosis and as a palliative treatment of certain cancers. Use of Depo-Provera has been associated with an increased risk of significant bone mineral density loss, including a significantly increased risk of developing osteoporosis at ages below the statistical norm.
For further information concerning this action, please contact Kim Mitchell at 1-800-461-6166 ext. 2374 or email kim.mitchell@siskinds.com.
 |
Acrobat Reader is required to view and print files that are in PDF format. If you don't have it, you can download it for free here. |
 Back to Siskinds Actions
|
